Johnson & Johnson (JNJ) 107.35 $JNJ
Final Glance: Pharmaceuticals companies
AP - 1 hr 48 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:
Final Glance: Medical Devices companies
AP - 1 hr 48 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Midday Glance: Medical Devices companies
AP - Thu Sep 18, 12:18PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Thu Sep 18, 12:18PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 1 p.m.:
Gilead Sciences, inc. Stock's Incoming Game Changer
Todd Campbell, The Motley Fool - Motley Fool - Thu Sep 18, 7:45AM CDT
Gilead Sciences ' Sovaldi may have revolutionized hepatitis C treatment, but it also served as a lightning rod of controversy over drugmakers' pricing of next-generation medicines. Sovaldi's ability to clear the virus in 90% of patients over 12...
First Bellwether Trial in the DePuy Orthopaedics Pinnacle Hip Device Litigation Continues in its Third Week, Parker Waichman LLP Comments
PRWeb - Wed Sep 17, 5:01PM CDT
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that the first bellwether trial involving Johnson & Johnson's DePuy Orthopaedics Pinnacle hip device is entering its third week and DePuy executives have been called to testify. The case is Herlihy-Paoli v. DePuy Orthopaedics Inc., U.S. District Court, Northern District of Texas (Dallas) (Case No.: 11-cv-3590).
Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org
PRWeb - Wed Sep 17, 9:31AM CDT
"North America Gynecological Devices Market Outlook to 2020″, provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)) Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10486 . The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Complete Report Details Available @ http://www.marketoptimizer.org/north-america-...-2020.html . Overview of Key Companies in North America Gynecological Devices Market: Conceptus, Inc. Hologic, Inc. Boston Scientific Corporation Cook Group Incorporated CooperSurgical, Inc. Merit Medical Systems, Inc. Utah Medical Products, Inc. Johnson & Johnson BSD Medical Corporation Scope Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Gynecological Devices market. Global corporate-level profiles of key companies operating within the Gynecological Devices market. Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Inquire before Buying @ http://www.marketoptimizer.org/contacts/inqui...name=10486 . (This is a premium report priced at US$3000 for a single user License.)
Early Glance: Pharmaceuticals companies
AP - Wed Sep 17, 9:29AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Wed Sep 17, 9:29AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Global Cardiovascular Monitoring and Diagnostic Devices Market Forecasts and Opportunities, 2019
M2 - Wed Sep 17, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8sv4vw/cardiovascular) has announced the addition of the "Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Cardiovascular diseases have been the leading cause of death worldwide and will be the leading cause till 2030, according to World Health Organization (WHO) These factors which result in obesity and hypertension are also identified as the underlying cause of cardiovascular disorders. The number of people diagnosed with coronary artery disease, peripheral artery disease, pulmonary embolism and congenital heart disease is rising rapidly worldwide. Therefore, the need for preventive healthcare has arisen and realized by countries with high burden of these disorders. Thus, the demand for cardiovascular monitoring and diagnostic devices is expected to rise in such countries. Aging is one of the major factors driving the demand for cardiovascular monitoring and diagnostic devices. As the aging process advents, the risk of hypertension, weakening of heart muscles, obesity and diabetes grows, thus increasing the risk of cardiovascular diseases. Moreover, advent of new technologies enabling portability in handling and performing the test will drive the global cardiovascular monitoring and diagnostic devices market further. For example, technologies such as implantable loop recorders and wearable heart rate monitors would compel other players in the market to pace up with their product technologies, which will fuel the market growth. Based on the product type, the global cardiovascular monitoring and diagnostic devices market is categorized into six segments namely ECG systems, cardiovascular diagnostic catheters, holter monitors, event monitors, implantable loop recorders and ECG management systems. Among these, ECG systems held the majority share of the global cardiovascular monitoring and diagnostic devices market in 2012, while the global market for implantable loop recorders is expected to grow at a faster pace during the forecast period. The ECG systems market is majorly dominated by the resting ECG systems owing to higher demand from customers due to convenience in the procedure. The demand for these systems will rise further owing to their lower price and rising demand from patients. Also, it is more convenient to be used among elderly patients and patients at high risk of congestive heart failure. Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type - ECG Systems - Stress ECG - Resting ECG - Cardiovascular Diagnostic Catheters - Event Monitors - Holter Monitors - Implantable Loop Recorders - ECG Management Systems Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Product Type Chapter 5 Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Boston Scientific Corporation - Covidien plc - FUKUDA DENSHI Co., Ltd. - GE Healthcare - Johnson & Johnson - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare - Sorin Group - Spacelabs Healthcare - St. Jude Medical, Inc. - Welch Allyn - iemens Healthcare For more information visit http://www.researchandmarkets.com/research/8s...iovascular
Global Hepatitis C Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Gilead, Johnson & Johnson, Merck and Vertex Pharmaceuticals
PR Newswire Europe - Wed Sep 17, 6:26AM CDT
DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets [http://www.researchandmarkets.com/research/n8ttk9/global_hepatitis] has announced the addition of the "Global Hepatitis C Market 2014-2018" [http://www.researchandmarkets.com/research/n8ttk9/global_hepatitis] report to their offering.
Watch for Johnson & Johnson to Potentially Pullback After Gaining 1.11% Yesterday
Comtex SmarTrend(R) - Tue Sep 16, 3:48PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.11%
Comtex SmarTrend(R) - Tue Sep 16, 3:47PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Why It's Time for Allergan Shareholders to Take Some Profits
at The Street - Tue Sep 16, 12:09PM CDT
The current dividend does not pay enough for investors to stay.
Final Glance: Pharmaceuticals companies
AP - 1 hr 48 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:
Final Glance: Medical Devices companies
AP - 1 hr 48 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Midday Glance: Medical Devices companies
AP - Thu Sep 18, 12:18PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Midday Glance: Pharmaceuticals companies
AP - Thu Sep 18, 12:18PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 1 p.m.:
Gilead Sciences, inc. Stock's Incoming Game Changer
Todd Campbell, The Motley Fool - Motley Fool - Thu Sep 18, 7:45AM CDT
Gilead Sciences ' Sovaldi may have revolutionized hepatitis C treatment, but it also served as a lightning rod of controversy over drugmakers' pricing of next-generation medicines. Sovaldi's ability to clear the virus in 90% of patients over 12...
First Bellwether Trial in the DePuy Orthopaedics Pinnacle Hip Device Litigation Continues in its Third Week, Parker Waichman LLP Comments
PRWeb - Wed Sep 17, 5:01PM CDT
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that the first bellwether trial involving Johnson & Johnson's DePuy Orthopaedics Pinnacle hip device is entering its third week and DePuy executives have been called to testify. The case is Herlihy-Paoli v. DePuy Orthopaedics Inc., U.S. District Court, Northern District of Texas (Dallas) (Case No.: 11-cv-3590).
Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org
PRWeb - Wed Sep 17, 9:31AM CDT
"North America Gynecological Devices Market Outlook to 2020″, provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)) Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10486 . The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Complete Report Details Available @ http://www.marketoptimizer.org/north-america-...-2020.html . Overview of Key Companies in North America Gynecological Devices Market: Conceptus, Inc. Hologic, Inc. Boston Scientific Corporation Cook Group Incorporated CooperSurgical, Inc. Merit Medical Systems, Inc. Utah Medical Products, Inc. Johnson & Johnson BSD Medical Corporation Scope Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Gynecological Devices market. Global corporate-level profiles of key companies operating within the Gynecological Devices market. Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Inquire before Buying @ http://www.marketoptimizer.org/contacts/inqui...name=10486 . (This is a premium report priced at US$3000 for a single user License.)
Early Glance: Pharmaceuticals companies
AP - Wed Sep 17, 9:29AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Wed Sep 17, 9:29AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Global Cardiovascular Monitoring and Diagnostic Devices Market Forecasts and Opportunities, 2019
M2 - Wed Sep 17, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8sv4vw/cardiovascular) has announced the addition of the "Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Cardiovascular diseases have been the leading cause of death worldwide and will be the leading cause till 2030, according to World Health Organization (WHO) These factors which result in obesity and hypertension are also identified as the underlying cause of cardiovascular disorders. The number of people diagnosed with coronary artery disease, peripheral artery disease, pulmonary embolism and congenital heart disease is rising rapidly worldwide. Therefore, the need for preventive healthcare has arisen and realized by countries with high burden of these disorders. Thus, the demand for cardiovascular monitoring and diagnostic devices is expected to rise in such countries. Aging is one of the major factors driving the demand for cardiovascular monitoring and diagnostic devices. As the aging process advents, the risk of hypertension, weakening of heart muscles, obesity and diabetes grows, thus increasing the risk of cardiovascular diseases. Moreover, advent of new technologies enabling portability in handling and performing the test will drive the global cardiovascular monitoring and diagnostic devices market further. For example, technologies such as implantable loop recorders and wearable heart rate monitors would compel other players in the market to pace up with their product technologies, which will fuel the market growth. Based on the product type, the global cardiovascular monitoring and diagnostic devices market is categorized into six segments namely ECG systems, cardiovascular diagnostic catheters, holter monitors, event monitors, implantable loop recorders and ECG management systems. Among these, ECG systems held the majority share of the global cardiovascular monitoring and diagnostic devices market in 2012, while the global market for implantable loop recorders is expected to grow at a faster pace during the forecast period. The ECG systems market is majorly dominated by the resting ECG systems owing to higher demand from customers due to convenience in the procedure. The demand for these systems will rise further owing to their lower price and rising demand from patients. Also, it is more convenient to be used among elderly patients and patients at high risk of congestive heart failure. Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type - ECG Systems - Stress ECG - Resting ECG - Cardiovascular Diagnostic Catheters - Event Monitors - Holter Monitors - Implantable Loop Recorders - ECG Management Systems Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Product Type Chapter 5 Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Boston Scientific Corporation - Covidien plc - FUKUDA DENSHI Co., Ltd. - GE Healthcare - Johnson & Johnson - Medtronic, Inc. - Nihon Kohden Corporation - Philips Healthcare - Sorin Group - Spacelabs Healthcare - St. Jude Medical, Inc. - Welch Allyn - iemens Healthcare For more information visit http://www.researchandmarkets.com/research/8s...iovascular
Global Hepatitis C Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Gilead, Johnson & Johnson, Merck and Vertex Pharmaceuticals
PR Newswire Europe - Wed Sep 17, 6:26AM CDT
DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets [http://www.researchandmarkets.com/research/n8ttk9/global_hepatitis] has announced the addition of the "Global Hepatitis C Market 2014-2018" [http://www.researchandmarkets.com/research/n8ttk9/global_hepatitis] report to their offering.
Watch for Johnson & Johnson to Potentially Pullback After Gaining 1.11% Yesterday
Comtex SmarTrend(R) - Tue Sep 16, 3:48PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.11%
Comtex SmarTrend(R) - Tue Sep 16, 3:47PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Why It's Time for Allergan Shareholders to Take Some Profits
at The Street - Tue Sep 16, 12:09PM CDT
The current dividend does not pay enough for investors to stay.
